Claim: Scientists discovered that mRNA cancer vaccines remain highly effective even when the key immune cell thought to be essential is removed, because a completely unexpected backup immune cell steps in, overturning a core assumption of cancer i

The claim that mRNA cancer vaccines remain effective without a key immune cell is mostly true. Research from reputable sources like ScienceDaily and Nature supports this finding, indicating that backup immune cells can activate T cells and combat tumors effectively. However, the claim challenges established assumptions in cancer immunotherapy, which may lead to skepticism among some experts who are cautious about overturning long-held beliefs without extensive validation. This nuance is important in understanding the implications of the research. The graders agree on direction, but vary in strength. Gemini comes in highest (98%), while OpenAI is lowest (85%). While the evidence strongly supports the claim, there may be some skepticism from experts who are concerned about the broader implications of these findings. They might argue that the effectiveness of mRNA vaccines without the key immune cell could vary in different contexts or patient populations. Additionally, the long-term effects and mechanisms of the backup immune cells are still under investigation, which could influence the overall acceptance of this claim in the scientific community. Thus, while the evidence is compelling, it does not completely eliminate uncertainty regarding the claim's implications in all scenarios.